Onderzoeker
Tom Delanghe
- Disciplines:Analyse van next-generation sequence data, Adaptieve immunologie, Bacteriologie
Affiliaties
- Vandenabeele Lab (Onderzoeksgroep)
Lid
Vanaf1 jan 2017 → Heden
Publicaties
1 - 9 van 9
- RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD.(2023)
Auteurs: Yves Dondelinger, Tom Delanghe, Peter Vandenabeele, Mathieu Bertrand
Pagina's: 2201506 - NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis.(2023)
Auteurs: Yves Dondelinger, Dario Priem, Jon Huyghe, Tom Delanghe, Peter Vandenabeele, Mathieu Bertrand
Pagina's: 755 - The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach.(2022)
Auteurs: Yves Dondelinger, Tom Delanghe, Mathieu Bertrand
Pagina's: 1016 - Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.(2021)
Auteurs: Tom Delanghe, Jon Huyghe, Dario Priem, Samya Van Coillie, Peter Vandenabeele, Yves Dondelinger, Mathieu Bertrand
Pagina's: 699 - Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation.(2020)
Auteurs: Tom Delanghe, Mathieu Bertrand
Pagina's: 1747 - RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.(2020)
Auteurs: Tom Delanghe, Yves Dondelinger, Mathieu Bertrand
Pagina's: 189-200 - Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation(2019)
Auteurs: Yves Dondelinger, Tom Delanghe, Dario Priem, Diego Rojas Rivera, Ria Roelandt, Savvas Savvides, Peter Vandenabeele, Mathieu Bertrand
Pagina's: 1729 - MK2 puts an additional brake on RIPK1 cytotoxic potential(2018)
Auteurs: Yves Dondelinger, Tom Delanghe, Mathieu Bertrand
Pagina's: 457-459 - MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death(2017)
Auteurs: Yves Dondelinger, Tom Delanghe, Diego Rojas Rivera, Dario Priem, Tinneke Delvaeye, Peter Vandenabeele, Mathieu Bertrand
Pagina's: 1237-1247